Work

Supplementary Fig. S2 from Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Fig.S2 shows data shows specificity of CIDD-0149897 using ER beta KO cells.

DOI: 10.1158/1535-7163.24474347

Authors: Uday P. Pratap, Michael Tidwell, Henriette U. Balinda, Nicholas A. Clanton, Xue Yang, Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Dong Liang, Huan Xie, Yidong Chen, Zhao Lai, Rajeshwar R. Tekmal, Stanton F. McHardy, Andrew J. Brenner, Ratna K. Vadlamudi

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4388112052

Cites:

Cited by:

Related to: 10